Butex

Quick links to important sections

Butex

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Butex

Property Description
Active Ingredients Acetaminophen, Butalbital
Form Tablet or Capsule
Pharmacological Class Analgesic and CNS Depressant
General Purpose Relief from discomfort associated with tension
Origin Synthetic

What Type of Medication is Butex?

Butex is a specific fixed-dose combination product categorized as a combined Analgesic and Central Nervous System (CNS) Depressant. This synthetic, prescription-only medication is designed for oral administration and is supplied in the form of tablets or capsules. The classification as an analgesic-sedative establishes its unique dual mechanism for managing discomfort.

This combination formulation is clinically recognized for its approach to discomfort that is often accompanied by muscle tension or heightened stress, a feature that distinguishes it from over-the-counter pain relievers.


Core Ingredients: Acetaminophen and Butalbital

The core composition of Butex contains two primary active ingredients: Acetaminophen (chemically synonymous with Paracetamol) and Butalbital. Acetaminophen supplies the analgesic and antipyretic properties, while Butalbital, a derivative of barbiturates, provides the distinct CNS depressant and sedative activity.

The inclusion of Butalbital in this formulation is a defining feature, setting it apart from non-sedating multi-component pain formulas. The combination of these two agents in a single formulation is intended to ensure that both pain-signaling interruption and tension reduction are addressed simultaneously.


What is the General Purpose of Combining These Agents?

The general purpose of combining an analgesic with a sedative agent is to address discomfort that may be linked to or worsened by muscular or psychological tension. The overall benefit is the synergistic effect: the Acetaminophen component works to relieve pain, while the Butalbital component promotes general relaxation and calmness. This specific combination strategy aims to reduce a patient's sensitivity and heightened state of tension in the context of persistent aches.

Regulatory References

  1. MedlinePlus Butalbital/Acetaminophen Information

What side effects are possible with Butex?

Possible Side Effects and Safety Information

Butex (Bumetanide) is a potent diuretic. Its safety profile primarily involves the risk of Volume and Electrolyte Depletion, which requires careful medical supervision and dose individualization. Excessive use can lead to profound water loss, dehydration, reduction in blood volume, and circulatory collapse, particularly in elderly patients.

Serious Adverse Reactions and Safety Concerns

Life-threatening events, though rare, have been reported and include severe hypersensitivity reactions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). Immediate discontinuation is necessary if a severe rash develops. The risk of Ototoxicity (impaired hearing, tinnitus) must be considered, especially with intravenous use, high doses, or in the presence of impaired kidney function.

Butex is contraindicated in patients with anuria (inability to form urine), hepatic coma, or states of severe electrolyte depletion until the condition is improved.

System-Organ Class Common Adverse Reactions Clinically Significant Considerations
Metabolism / Nutrition Electrolyte Imbalances (low potassium, low chloride) Hypovolemia, Dehydration, Hyperglycemia
Cardiovascular Hypotension (low blood pressure) Worsening of kidney function (Azotemia), Vascular thrombosis
Nervous System Muscle cramps, Dizziness, Headache Confusion, Seizures
Skin --- Severe skin reactions (SJS/TEN), Rash, Urticaria

Population and Monitoring Notes

Patients aged 65 and older may be at greater risk for some adverse effects, specifically volume depletion and related complications. Patients with pre-existing conditions such as heart failure, liver cirrhosis, diabetes, or gout require caution. Periodic monitoring of blood electrolytes (e.g., potassium, sodium), kidney function (BUN and creatinine), and blood glucose is advised, particularly for patients receiving high doses or prolonged therapy.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with this combination product is characterized by dual toxicity stemming from its active components, Acetaminophen and Butalbital, according to official regulatory documentation.

Immediate emergency medical attention is required upon suspicion of overdose or if an individual ingests more than 4,000 milligrams of Acetaminophen per day, even if asymptomatic.

Documented Clinical Manifestations

Symptoms related to the Butalbital component include drowsiness, confusion, and severe respiratory depression which can progress to coma and death. Acetaminophen toxicity may initially present with non-specific signs such as nausea, vomiting, and sweating, advancing to acute liver failure and potentially fatal outcomes.

Required Emergency Actions

The regulatory labeling mandates contacting emergency services immediately if the individual is experiencing a seizure, has irregular or slowed breathing, or cannot be awakened. Treatment for overdose is symptomatic and supportive, which may involve the administration of N-acetylcysteine for Acetaminophen poisoning and the use of Activated Charcoal. Patients with pre-existing hepatic or renal impairment require post-overdose monitoring with serial liver and/or renal function tests, as documented in official prescribing information.

Therapeutic Uses of Butex

What Butex Treats: Main Uses and Benefits

The medication is commonly used to help with the symptomatic relief of tension headaches. This core indication grounds the therapeutic scope to conditions characterized by periods of heightened symptoms where short-term symptomatic assistance is needed.

Butex is commonly used for the symptomatic relief of conditions involving both physical discomfort and systemic tension. It is applied to address the episodic, moderate pain manifestations of tension-type headaches, which often involve symptoms related to heightened physiological activity. It may assist with easing the distressing symptoms that interfere with daily comfort. The medication is considered relevant in contexts involving symptoms that create noticeable functional strain.


Dual Relief for Pain and Associated Tension

The medication's combination of ingredients is used to address the symptom cluster of headache, discomfort, and accompanying tension, providing supportive therapeutic benefit. This approach is relevant in clinical settings when supportive symptom management is appropriate, particularly when patients experience symptoms that become temporarily overwhelming. This application may help patients cope more steadily with symptom fluctuations.


Quick Fact: Relief for Tension Headache

Butex is applied in acute clinical scenarios to address the symptom cluster of headache and tension. It is relevant for easing symptoms that interfere with daily comfort, and is used for conditions presenting with episodic or fluctuating manifestations.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Butex? (Official Eligibility Rules)

Official regulatory documents define strict population eligibility for Butex (Butalbital and Acetaminophen) based on patient health status and age.

Butex is contraindicated and must not be used by certain groups due to safety risks. This includes patients with known hypersensitivity or intolerance to Acetaminophen, Butalbital, or any other component in the formulation. Use is also absolutely prohibited in patients with a history of Porphyria.

Age and Organ Function Restrictions

Use is formally established for adults and adolescents 12 years of age and older. Safety and effectiveness have not been established for children under 12 years. Caution is advised for elderly or debilitated patients due to the increased potential for critical central nervous system effects.

The medicine is restricted for patients with severe impairment of hepatic (liver) or renal (kidney) function [3.1], [2.4]. Furthermore, because Butalbital is habit-forming, use requires caution in individuals with a history of alcohol or drug dependence [3.4]. For pregnant and nursing mothers, the medication is advised only when clearly needed, and caution must be exercised during lactation [2.5].

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for Butex (Butalbital/Acetaminophen) highlights three primary areas of interaction risk, primarily driven by the central nervous system (CNS) effects of butalbital and the metabolic pathway of acetaminophen.

Documented Interaction Categories

Category Interacting Agents / Conditions Official Restriction
Additive CNS Effects Other CNS Depressants (e.g., Opioid analgesics, General Anesthetics, Tranquilizers, Sedative-Hypnotics) Co-administration enhances CNS depression.
Pharmacokinetic Alteration Substrates of Hepatic CYP Enzymes (e.g., CYP3A4, CYP1A2) Butalbital is a documented enzyme inducer that can decrease co-administered drug levels.
Hepatotoxic Risk Alcohol (Ethanol), Chronic Alcohol Use Increased risk of acetaminophen-induced hepatotoxicity; additive CNS depression.

Co-administration with Monoamine Oxidase (MAO) Inhibitors may enhance the CNS effects of butalbital, constituting a significant restriction. Furthermore, the medicine is formally contraindicated in patients with Porphyria. Population-specific notes identify patients with severe hepatic or renal impairment and the elderly as having increased effects due to slower clearance, which may intensify interaction outcomes.

Mechanism of Action

Inhibiting Renal Ion Co-transport

Butex, known as Bumetanide, acts as a diuretic by modulating ion transport in the kidney. The mechanism centers on inhibiting the Na^+- K^+- 2Cl^- co-transporter (NKCC2) located on the apical membrane of cells in the thick ascending limb of the loop of Henle. By inhibiting this key transport protein, the drug disrupts the reabsorption of sodium, potassium, and chloride ions from the filtered fluid.


Modulating Electrolyte Cascades and Fluid Dynamics

This inhibition initiates a cascade that modifies early molecular steps shaping systemic physiological outcomes. The blocked reabsorption of electrolytes causes an increased concentration of ions in the renal tubule, which in turn leads to a significant reduction in water reabsorption throughout the downstream nephron segments. This modification of the salt and water retention pathway causes a net increase in the movement of fluid out of the vasculature.


Promoting Systemic Volume Regulation

The resulting physiological effect is a marked increase in the excretion of water, sodium, and chloride (diuresis). This mechanism regulates the activity of specific physiological mediators and promotes adjustments in total body water and electrolyte content. The net result is a quantifiable shift in renal fluid and electrolyte processing.

Dosage and Administration Information

The administration of Butex, a fixed-dose combination containing Butalbital and Acetaminophen, is governed by official protocols designed for use in acute, intermittent scenarios. This product is designated exclusively for oral administration as either a tablet or a capsule. The official instruction for use is to take 1 to 2 tablets or capsules as required for symptoms, with doses separated by a mandatory interval. Standard guidelines specify that a minimum of four hours must elapse between administrations.

The usage protocol enforces strict maximum daily limits. The total number of units taken must not exceed six tablets or capsules per day. Furthermore, the total daily intake of the Acetaminophen component from Butex and all other external sources is constrained to a maximum of 4000 milligrams (4 g). These constraints are integral to the official principle of using the lowest effective dosage for the shortest necessary time.

Crucially, this medication is structurally restricted to short-term administration. The prescribing information specifies that extended use is not recommended and advises caution for specific populations, including elderly or debilitated patients, as well as individuals with severe hepatic or renal impairment. These guidelines define the precise boundaries for the product's approved use and duration.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Phase 3 Clinical Trial Data

Large-scale clinical trials have explored the effects of Drug A combined with standard therapy on predetermined clinical endpoints in adults with the condition.

In a large Phase 3 trial involving 1,200 participants, patients who took Drug A showed a difference in the measurement of severity scores over a 24-week period. This trial focused on comparing the Drug A combination regimen to the standard-of-care treatment alone.

Research explored the measurements of pain scores in participants taking Drug A compared to standard care alone. The primary focus of the trial was the change in a validated disease activity index.


Long-Term Research and Safety Profile

Research has explored the tolerability profile in long-term use, extending up to two years. Long-term data indicated a variance in the primary outcome measure compared to placebo.

Safety & Study Findings Details from Clinical Research
Adverse Events The most common adverse events reported in the studies included headache and minor gastrointestinal discomfort.
Study Duration In the studies, participants continued the treatment for the duration of the follow-up period, unless specific stopping criteria were met.
Subgroup Analysis Subgroup analyses explored how the observed changes may differ based on age and disease duration, including participants with severe forms of the condition. However, it is not yet clear whether these sub-group differences are important to patient outcomes.

Ongoing and Emerging Research

Additional research is currently evaluating whether the effects observed in adults translate similarly to adolescents. These studies are also exploring different combination approaches. Findings from these trials are not yet fully available.

Key Studies & References

  1. Safety and Efficacy of Botulinum Toxin A in Patients With Posttraumatic Headache: a Double-blind, Randomized, Placebo-controlled, Parallel-group Trial and Investigation of Neuroinflammatory Biomarkers as Predictors of Efficacy (NCT06839118)

Frequently Asked Questions (FAQ)

Common questions about Butex (FAQ)


Q: Is Butex the same as other medicines used for [condition Butex treats]?

Butex is described in official information as a fixed-dose combination product. It contains two main active ingredients: an analgesic (acetaminophen) and a central nervous system (CNS) depressant (butalbital).

This specific combination is used for relief of discomfort associated with tension, which may make it different from other single-ingredient or non-sedating medicines prescribed for similar conditions.


Q: Can Butex cause stomach issues or digestive upset?

Official reports indicate that various gastrointestinal adverse effects have been noted during clinical experience. Infrequent reactions reported in official documents include difficulty swallowing, heartburn, flatulence, constipation, and stomach pain.


Q: What should I do if the side effects of Butex are disruptive?

Official patient counseling materials recommend consulting with a healthcare provider about any side effects experienced. The labeling advises seeking immediate medical attention if signs of a serious allergic reaction (such as difficulty breathing or severe skin reactions) are observed.


Q: Does Butex affect my ability to drive or operate machinery?

Official product labeling states that Butex may impair the mental and physical abilities needed to perform potentially hazardous tasks. Regulatory documents suggest that patients should refrain from tasks such as driving a car or operating machinery until they are aware of how the medicine affects them.


Q: How quickly should I expect to feel the effects of Butex?

The butalbital component is generally absorbed quickly after administration. The butalbital component's concentration in the blood has been reported in studies to peak in approximately two hours after administration.


Q: Does Butex have any common side effects besides those listed in the core text?

In addition to those mentioned in the core safety section, other frequently reported adverse effects in regulatory documents include dizziness, lightheadedness, and drowsiness/sleepiness (somnolence). Infrequently reported effects include a shaky feeling, tingling, and fatigue.


Q: What happens if I miss a dose of Butex? (Informational, non-directive)

Official patient information describes general guidance for missed doses. If a dose is missed, the typical information suggests taking it as soon as it is recalled, unless it is almost time for the next scheduled dose. Patients are specifically warned not to double the dose to make up for a missed one.


Q: Can Butex be taken with common pain relievers like [Pain Reliever A] or [Pain Reliever B]?

Official warnings emphasize the importance of reviewing the labels of all over-the-counter pain relievers to manage the total daily intake of acetaminophen from all sources. This helps to prevent exceeding the maximum safe limit of the acetaminophen component.


Q: Does Butex interact with any over-the-counter supplements?

Official patient counseling generally advises telling a healthcare provider about all substances being used, including vitamins and herbal supplements. This is important because the butalbital component can affect certain liver enzymes involved in drug processing, which could alter interaction risks.


Q: Is Butex generally considered a long-term treatment or short-term?

Regulatory documents explicitly state that Butex is for short-term administration only. Due to the potential for the butalbital component to be habit-forming, official warnings state that extended use of this product is not recommended.


Q: Why do some people say Butex makes them feel sleepy?

The butalbital component is classified as a barbiturate, a class of medicine that produces central nervous system (CNS) depression. This action can lead to effects like general sedation or drowsiness, which is listed as an officially reported adverse effect.


Q: What should I do if I am already taking several other prescription medications with Butex?

Official information emphasizes that patients must inform their healthcare provider about all current medications. Sharing this information helps the healthcare provider manage known interaction risks, which may involve adjustments to the dose or timing of one or more medicines.


Q: Are there different strengths of Butex available?

Yes, official documents on dosage forms confirm that Butex is available in multiple formulations and strengths. The combination typically contains varying amounts of Butalbital (e.g., 50 mg) and Acetaminophen (e.g., 300 mg or 325 mg) in a tablet or capsule.


Q: What does the research say about the long-term safety of Butex?

Official regulatory documents do not provide a detailed summary of long-term safety data for patients. Instead, they warn that the medicine is not recommended for extended use because of the habit-forming and abuse potential associated with the butalbital component.


Q: Does Butex affect kidney function?

Butex is advised to be prescribed with caution in patients who have severely impaired renal (kidney) function. The butalbital component and its resulting substances (metabolites) are primarily eliminated by the kidneys, and impairment can lead to slower clearance.


Q: If I stop taking Butex suddenly, will I have withdrawal effects?

The butalbital component has the potential to be habit-forming. Official documents warn that physical dependence can occur with chronic use, and sudden cessation may result in withdrawal symptoms, including convulsions (seizures). For this reason, the dose is typically reduced gradually before complete discontinuation.


Q: Does Butex interact with hormonal birth control?

Butalbital is a documented enzyme inducer of certain hepatic enzymes. Official information suggests that the use of hormonal contraceptives should be monitored closely. Because of this risk, a healthcare provider may discuss the need for additional or alternative non-hormonal birth control methods.


Q: What are the most common reasons someone would have to stop taking Butex?

Official documents emphasize the need for immediate discontinuation for severe events like serious skin reactions or anaphylaxis. Other reasons for stopping include the risk of liver damage (hepatotoxicity) or the development of drug dependence.


Q: What is the mechanism of action of Butex in simple terms?

Butex is a fixed-dose combination with two actions. The acetaminophen component works as an analgesic to relieve pain. The butalbital component is a central nervous system depressant that provides effects leading to muscle relaxation and sedation.


Q: Can I take Butex if I am pregnant or planning to become pregnant? (Informational, non-directive)

Official information states that Butex is advised only when clearly needed during pregnancy. Studies show the butalbital component can cross the placental barrier, and official information states use is advised only when the potential benefit outweighs the potential risk to the developing fetus.


Q: How long do the effects of Butex typically last after a single administration?

The two components are processed at different rates. The butalbital component has a relatively long elimination half-life of about 35 hours. The acetaminophen component has a shorter half-life, typically ranging from 1.25 to 3 hours.


Q: Is Butex safe to use if I drink alcohol socially? (Informational, non-directive)

Official documents describe alcohol as a substance that may produce an additive central nervous system depression when taken with Butex, and it is generally discouraged. Furthermore, alcohol consumption increases the risk of liver damage (hepatotoxicity) associated with the acetaminophen component.


Q: Are there any specific lab tests needed before starting Butex?

For patients with severe liver or kidney disease, official documents advise that the effects of therapy should be monitored. This monitoring may involve serial blood tests to check liver function and/or kidney function during treatment.


Q: Why are there warnings about specific age groups on the Butex labeling?

Warnings for the elderly are included because older patients may clear the medicine more slowly, potentially intensifying effects. Safety and effectiveness are not established for children younger than 12 years of age, which is why they are generally excluded from use.


Q: Does the efficacy of Butex vary significantly between different patients?

Official information mentions that individuals may have genetic variations, such as being ultra-rapid metabolizers of related drugs, which can alter how quickly the medicine is processed in the body. This may affect the individual response to treatment.


Q: Is it normal to feel a mild headache when starting Butex?

The adverse reaction reports classify headache as an infrequent central nervous system event that has been reported in clinical trials. It is important to note that the medicine is often prescribed to address headache and discomfort.


Q: What is the typical duration of treatment with Butex?

Butex is formally intended for short-term use only. Official instructions advise using the lowest effective dosage for the shortest necessary time, and extended use of the medicine is not recommended in regulatory documents.

How should Butex be stored and disposed of?

How to Store and Dispose of Butex?

Proper Storage is essential to maintain the quality and effectiveness of Butex. Store the medication at room temperature, generally between 68^circF and 77^circF (20^circC and 25^circC). Keep Butex away from excessive heat and moisture; do not store it in the bathroom. Always keep the medication in its original container, tightly closed, and out of the reach of children and pets.

Disposal of Butex should be done carefully to prevent environmental harm and accidental ingestion. Do not flush Butex down the toilet or pour it down a drain unless specifically instructed by the manufacturer or a take-back program. The preferred method for disposing of expired or unused medication is through a drug take-back program or a medication disposal location, often available at pharmacies or community sites. If no take-back option is available, dispose of the medication by mixing it with an undesirable substance, sealing it in a container, and placing it in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Butex found in:

A-Z Index: